Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Design Therapeutics	Apria	Thoma Bravo Advantage	ThredUp	Bioventus
Symbol	NASDAQ:DSGN	NYSE:APR	NYSE:TBA	NASDAQ:TDUP	NYSE:BVS
Price Information
Current Price	$22.29	$28.18	$10.14	$18.50	$15.91
52 Week Range	Buy	Buy	N/A	Buy	Buy
MarketRank™
Overall Score	1.3	1.4	0.0	1.6	1.4
Analysis Score	3.3	2.5	0.0	3.4	2.5
Community Score	3.3	4.5	0.0	4.5	4.5
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	0.0	0.0	0.0	0.0
Earnings & Valuation Score	0.0	0.0	0.0	0.0	0.0
Analyst Ratings
Consensus Recommendation	Buy	Buy	N/A	Buy	Buy
Consensus Price Target	$35.33	$29.20	N/A	$20.86	$19.50
% Upside from Price Target	58.52% upside	3.62% upside	N/A	12.74% upside	22.56% upside
Trade Information
Market Cap	$1.24 billion	$997.88 million	$1.04 billion	$1.68 billion	$904.09 million
Beta	N/A	N/A	N/A	N/A	N/A
Average Volume	178,354	258,904	1,431,948	785,818	238,881
Sales & Book Value
Annual Revenue	N/A	N/A	N/A	N/A	N/A
Price / Sales	N/A	N/A	N/A	N/A	N/A
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	N/A	N/A	N/A	N/A	N/A
Price / Book	N/A	N/A	N/A	N/A	N/A
Profitability
Net Income	N/A	N/A	N/A	N/A	N/A
EPS	N/A	N/A	N/A	N/A	N/A
Trailing P/E Ratio	0.00	0.00	0.00	0.00	0.00
Forward P/E Ratio	∞	∞	∞	∞	∞
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	N/A	N/A	N/A
Return on Equity (ROE)	N/A	N/A	N/A	N/A	N/A
Return on Assets (ROA)	N/A	N/A	N/A	N/A	N/A
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A
Ownership Information
Institutional Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Insider Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Miscellaneous
Employees	15	6,120	N/A	1,862	700
Shares Outstanding	55.62 million	35.21 million	102.40 million	90.86 million	56.83 million
Next Earnings Date	8/9/2021 (Estimated)	N/A	N/A	8/11/2021 (Estimated)	8/11/2021 (Estimated)
Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Source	Headline
	Bioventus (NYSE:BVS) Releases Quarterly Earnings Results americanbankingnews.com - May 13 at 1:36 PM
	Bioventus Inc. Reports First Quarter Results; Updates Full Year 2021 Financial Guidance finance.yahoo.com - May 12 at 7:42 PM
	Bioventus (NYSE:BVS) Issues FY 2021 Earnings Guidance americanbankingnews.com - May 12 at 5:50 PM
	Bioventus (NYSE:BVS) Sees Strong Trading Volume americanbankingnews.com - May 11 at 10:56 AM
	Bioventus (NYSE:BVS) Trading Up 9.3% americanbankingnews.com - May 10 at 6:16 PM
	Bioventus (BVS) Scheduled to Post Earnings on Wednesday americanbankingnews.com - May 5 at 2:08 AM
	Bioventus (NYSE:BVS) Shares Gap Down to $14.40 americanbankingnews.com - May 3 at 12:04 PM
	Bioventus (NYSE:BVS) Trading Up 4.2% americanbankingnews.com - April 28 at 12:38 PM
	Bioventus Announces First Commercial Shipment of the Bioness(R) Integrated Therapy System (BITS) Balance System marketwatch.com - April 28 at 10:02 AM
	Bioventus Announces First Commercial Shipment of the Bioness® Integrated Therapy System (BITS) Balance System finance.yahoo.com - April 27 at 8:44 AM
	Bioventus (NYSE:BVS) Price Target Raised to $19.00 at Morgan Stanley americanbankingnews.com - April 26 at 9:58 AM
	Bioventus (NYSE:BVS) Stock Price Down 2.8% americanbankingnews.com - April 21 at 1:38 PM
	Bioventus (NYSE:BVS) Trading 4.9% Higher After Analyst Upgrade americanbankingnews.com - April 20 at 1:18 PM
	Bioventus (NYSE:BVS) Shares Gap Down to $14.77 americanbankingnews.com - April 19 at 12:02 PM
	Morgan Stanley Raises Bioventus (NYSE:BVS) Price Target to $19.00 americanbankingnews.com - April 19 at 10:28 AM
	Bioventus to Release First Quarter of Fiscal Year 2021 Financial Results on May 12, 2021 finance.yahoo.com - April 12 at 8:08 PM
	Medtech firm Bioventus acquires California medical device company in deal worth up to $110M wraltechwire.com - March 31 at 12:58 PM
	Bioventus makes multimillion-dollar acquisition bizjournals.com - March 31 at 12:58 PM
	Bioventus Snaps Up Bioness; Street Remains Bullish smarteranalyst.com - March 31 at 7:57 AM
	Bioventus Acquires Bioness, Inc. finance.yahoo.com - March 30 at 8:34 PM
	Bioventus rises before hours on Street-beating Q4 massdevice.com - March 29 at 1:54 PM
	Can Bioventus Inc. (NASDAQ:BVS) still be hot this week? stocksregister.com - March 27 at 5:51 PM
	Bioventus’ 4Q Results Outperform Analysts’ Expectations finance.yahoo.com - March 26 at 6:47 AM
	Bioventus, Inc. Class A to Host Earnings Call finance.yahoo.com - March 25 at 7:50 PM
	Bioventus Inc. Reports Fourth Quarter and Full Year 2020 Financial Results; Introduces Full Year 2021 Financial Guidance finance.yahoo.com - March 25 at 7:50 PM

Date	Company	Brokerage	Action
4/26/2021	Design Therapeutics	Piper Sandler	Initiated Coverage
4/26/2021	Design Therapeutics	The Goldman Sachs Group	Initiated Coverage
4/26/2021	Design Therapeutics	SVB Leerink	Initiated Coverage
3/31/2021	Apria	Citigroup	Boost Price Target
3/8/2021	Apria	UBS Group	Initiated Coverage
3/8/2021	Apria	Bank of America	Initiated Coverage
5/13/2021	ThredUp	Wells Fargo & Company	Boost Price Target
5/13/2021	ThredUp	Telsey Advisory Group	Boost Price Target
5/13/2021	ThredUp	Barclays	Boost Price Target
4/26/2021	ThredUp	KeyCorp	Initiated Coverage
4/26/2021	ThredUp	Morgan Stanley	Initiated Coverage
4/26/2021	ThredUp	William Blair	Initiated Coverage
3/15/2021	Bioventus	JPMorgan Chase & Co.	Initiated Coverage
3/15/2021	Bioventus	Canaccord Genuity	Initiated Coverage

(Data available from 5/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources